As we get closer to the end of the year, we’re running more stories that look back at topics we examined in depth over the last several months, and several that offer well-informed predictions for the year ahead. This week, Bill Taranto, president of Merck’s Global Health Innovation Fund, wrote a TechCrunch+ article that explored […]
What you should know about working with corporate venture investment committees
Brian Walsh demystifies the role of the corporate venture capital investment committee and shines a light on how entrepreneurs can navigate some of the hidden pitfalls.
These two former corporate VCs just raised $110 million for their own fund
All kinds of teams are raising venture funds these days, so don’t be surprised to see more investors from corporate venture firms decide to create their own outfits, too. They might look to Counterpart Ventures for inspiration. Founded by Patrick Eggen and Joe Saijo, the three-year-old, San Francisco-based outfit just closed a $110 million fund […]
Corporate venture capital follows the same trend as other VC markets: Up
We’ve seen non-venture funds flow into the later stages of startup land, pushing VCs toward earlier-stage and more venture-y deals. Why would CVCs be immune to the same trend?
3 lies VCs tell ourselves about startup valuations
VCs need to stop engaging in self-delusion about why a valuation that is too high might be OK. Here are three common lies investors tell themselves to rationalize an undisciplined valuation decision.